OncoCyte Corporation

NASDAQ: OCX · Real-Time Price · USD
3.20
0.47 (17.22%)
At close: Jun 17, 2025, 3:59 PM

OncoCyte Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-60.66M -27.78M -72.9M -64.1M
Depreciation & Amortization
1.56M 1.68M 5.22M 4.21M
Stock-Based Compensation
1.91M 6.57M 10.04M 6.84M
Other Working Capital
n/a 677K -1.66M 373K
Other Non-Cash Items
37.79M 174K 14.01M 28.57M
Deferred Income Tax
n/a n/a n/a -9.26M
Change in Working Capital
n/a -3.97M -1.94M -2.2M
Operating Cash Flow
-20.71M -23.32M -45.57M -35.94M
Capital Expenditures
-516K -281K -4.34M -2.25M
Cash Acquisitions
n/a n/a n/a -11.71M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a 367K n/a n/a
Other Investing Acitivies
-512K -1.02M -4.34M -13.35M
Investing Cash Flow
-512K -932K -4.34M -13.96M
Debt Repayment
-201K -117K -1.43M -1.53M
Common Stock Repurchased
n/a -1.12M n/a -239K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-421K -427K -483K 2.15M
Financial Cash Flow
20.43M 12.19M 35.81M 78.36M
Net Cash Flow
-796K -12.07M -14.1M 28.46M
Free Cash Flow
-21.23M -23.61M -49.91M -38.19M